Anne Ammerdorffer

meta-analysis 2025

The prevalence and burden of heavy menstrual bleeding, and market access barriers of medical interventions with a focus on low- and middle-income countries: a scoping review

BMC women's health ·doi:10.1186/s12905-025-04157-5

BACKGROUND: Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss that negatively affects physical, emotional, social, and quality of life (QoL) of women at reproductive age. The aim of this systematic scoping review w…

review 2024

Eliminating gender bias in biomedical research requires fair inclusion of pregnant women and gender diverse people

Communications medicine ·doi:10.1038/s43856-024-00629-1

Systematic under-representation of pregnant women and gender diverse pregnant people in clinical research has prevented them from benefitting fairly from biomedical advances. The resulting lack of pharmacological safety and efficacy data le…

other 2023

The burden of heavy menstrual bleeding, and a market assessment of its medical interventions with a focus on low- and middle-income countries: a scoping review protocol

·doi:10.31219/osf.io/65t2f

The burden of heavy menstrual bleeding (HMB), the medical interventions for its treatment, and the market access to these products are three important topics needed to understand the current HMB environment in low-and middle income countrie…

observational 2020

Screening of Chlamydia trachomatis and Waddlia chondrophila Antibodies in Women with Tubal Factor Infertility

Microorganisms ·doi:10.3390/microorganisms8060918

Waddlia chondrophila is an emerging intracellular pathogen belonging to the order of Chlamydiales, and was previously associated with adverse pregnancy outcomes, as well as tubal factor infertility (TFI). In this study, we investigate the l…